“What we’re seeing is relatively poor performance in early users compared to our non-using controls, but not necessarily impairment.”- Dr. Mary Kathryn Dahlgren
Keep Up With McLean!
Receive the latest news in your inbox each month.
January 14, 2020
“What we’re seeing is relatively poor performance in early users compared to our non-using controls, but not necessarily impairment.”- Dr. Mary Kathryn Dahlgren